{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:06:41Z","timestamp":1785179201182,"version":"3.55.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T00:00:00Z","timestamp":1458086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T00:00:00Z","timestamp":1458086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human pluripotent stem cells provide a standardized resource for bone repair. However, criteria to determine which exogenous cells best heal orthopedic injuries remain poorly defined. We evaluated osteogenic progenitor cells derived from both human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs). Phenotypic and genotypic analyses demonstrated that these hESCs\/hiPSCs are similar in their osteogenic differentiation efficiency and they generate osteogenic cells comparable to osteogenic cells derived from mesenchymal stromal cells (BM-MSCs). However, expression of angiogenic factors, such as vascular endothelial growth factor and basic fibroblast growth factor in these osteogenic progenitor cells are markedly different, suggesting distinct pro-angiogenic potential of these stem cell derivatives. Studies to repair a femur non-union fracture demonstrate only osteogenic progenitor cells with higher pro-angiogenic potential significantly enhance bone repair <jats:italic>in vivo<\/jats:italic>. Together, these studies highlight a key role of pro-angiogenic potential of transplanted osteogenic cells for effective cell-mediated bone repair.<\/jats:p>","DOI":"10.1038\/srep22868","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T10:18:08Z","timestamp":1458123488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Angiogenic activity mediates bone repair from human pluripotent stem cell-derived osteogenic cells"],"prefix":"10.1038","volume":"6","author":[{"given":"Li","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Quanbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan E.","family":"Bechtold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan S.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,16]]},"reference":[{"key":"BFsrep22868_CR1","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/stem.103","volume":"27","author":"F Granero-Molto","year":"2009","unstructured":"Granero-Molto, F. et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27, 1887\u201398 (2009).","journal-title":"Stem Cells"},{"key":"BFsrep22868_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bone.2014.07.033","volume":"70","author":"E Gomez-Barrena","year":"2015","unstructured":"Gomez-Barrena, E. et al. Bone fracture healing: cell therapy in delayed unions and nonunions. Bone 70, 93\u2013101 (2015).","journal-title":"Bone"},{"key":"BFsrep22868_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1749-6632.2012.06551.x","volume":"1266","author":"K Sivasubramaniyan","year":"2012","unstructured":"Sivasubramaniyan, K. et al. Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets. Ann NY Acad Sci 1266, 94\u2013106 (2012).","journal-title":"Ann NY Acad Sci"},{"key":"BFsrep22868_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1741-7015-11-146","volume":"11","author":"G Siegel","year":"2013","unstructured":"Siegel, G. et al. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. BMC Med 11, 146 (2013).","journal-title":"BMC Med"},{"key":"BFsrep22868_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bone.2003.07.005","volume":"33","author":"K Stenderup","year":"2003","unstructured":"Stenderup, K., Justesen, J., Clausen, C. & Kassem, M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33, 919\u201326 (2003).","journal-title":"Bone"},{"key":"BFsrep22868_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1471-2121-9-60","volume":"9","author":"JD Kretlow","year":"2008","unstructured":"Kretlow, J. D. et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 9, 60 (2008).","journal-title":"BMC Cell Biol"},{"key":"BFsrep22868_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bone.2010.09.023","volume":"48","author":"L Harkness","year":"2011","unstructured":"Harkness, L. et al. Selective isolation and differentiation of a stromal population of human embryonic stem cells with osteogenic potential. Bone 48, 231\u201341 (2011).","journal-title":"Bone"},{"key":"BFsrep22868_CR8","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.bone.2010.06.020","volume":"47","author":"RA Kopher","year":"2010","unstructured":"Kopher, R. A. et al. Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells. Bone 47, 718\u201328 (2010).","journal-title":"Bone"},{"key":"BFsrep22868_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.stemcr.2015.01.008","volume":"4","author":"L Zou","year":"2015","unstructured":"Zou, L. et al. Use of RUNX2 expression to identify osteogenic progenitor cells derived from human embryonic stem cells. Stem Cell Reports 4, 190\u20138 (2015).","journal-title":"Stem Cell Reports"},{"key":"BFsrep22868_CR10","doi-asserted-by":"publisher","first-page":"8680","DOI":"10.1073\/pnas.1301190110","volume":"110","author":"GM de Peppo","year":"2013","unstructured":"de Peppo, G. M. et al. Engineering bone tissue substitutes from human induced pluripotent stem cells. Proc Natl Acad Sci USA 110, 8680\u20135 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep22868_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.5966\/sctm.2013-0154","volume":"3","author":"MD Phillips","year":"2014","unstructured":"Phillips, M. D. et al. Directed differentiation of human induced pluripotent stem cells toward bone and cartilage: in vitro versus in vivo assays. Stem Cells Transl Med 3, 867\u201378 (2014).","journal-title":"Stem Cells Transl Med"},{"key":"BFsrep22868_CR12","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1089\/scd.2014.0043","volume":"23","author":"JY Ko","year":"2014","unstructured":"Ko, J. Y., Park, S. & Im, G. I. Osteogenesis from human induced pluripotent stem cells: an in vitro and in vivo comparison with mesenchymal stem cells. Stem Cells Dev 23, 1788\u201397 (2014).","journal-title":"Stem Cells Dev"},{"key":"BFsrep22868_CR13","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.4161\/cc.9.23.14094","volume":"9","author":"U Ben-David","year":"2010","unstructured":"Ben-David, U., Benvenisty, N. & Mayshar, Y. Genetic instability in human induced pluripotent stem cells: classification of causes and possible safeguards. Cell Cycle 9, 4603\u20134 (2010).","journal-title":"Cell Cycle"},{"key":"BFsrep22868_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrc3034","volume":"11","author":"U Ben-David","year":"2011","unstructured":"Ben-David, U. & Benvenisty, N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 11, 268\u201377 (2011).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep22868_CR15","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrg3271","volume":"13","author":"RJ Lund","year":"2012","unstructured":"Lund, R. J., Narva, E. & Lahesmaa, R. Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet 13, 732\u201344 (2012).","journal-title":"Nat Rev Genet"},{"key":"BFsrep22868_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/stem.727","volume":"30","author":"Y Jung","year":"2012","unstructured":"Jung, Y., Bauer, G. & Nolta, J. A. Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 30, 42\u20137 (2012).","journal-title":"Stem Cells"},{"key":"BFsrep22868_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.scr.2009.02.002","volume":"2","author":"H Hentze","year":"2009","unstructured":"Hentze, H. et al. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res 2, 198\u2013210 (2009).","journal-title":"Stem Cell Res"},{"key":"BFsrep22868_CR18","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1158\/0008-5472.CAN-10-4402","volume":"71","author":"Z Ghosh","year":"2011","unstructured":"Ghosh, Z. et al. Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. Cancer Res 71, 5030\u20139 (2011).","journal-title":"Cancer Res"},{"key":"BFsrep22868_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tibtech.2006.10.010","volume":"25","author":"H Hentze","year":"2007","unstructured":"Hentze, H., Graichen, R. & Colman, A. Cell therapy and the safety of embryonic stem cell-derived grafts. Trends Biotechnol 25, 24\u201332 (2007).","journal-title":"Trends Biotechnol"},{"key":"BFsrep22868_CR20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nbt.1554","volume":"27","author":"K Miura","year":"2009","unstructured":"Miura, K. et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 27, 743\u20135 (2009).","journal-title":"Nat Biotechnol"},{"key":"BFsrep22868_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.stem.2012.11.015","volume":"12","author":"U Ben-David","year":"2013","unstructured":"Ben-David, U. et al. Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell 12, 167\u201379 (2013).","journal-title":"Cell Stem Cell"},{"key":"BFsrep22868_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4248\/BR201303001","volume":"1","author":"M Marenzana","year":"2013","unstructured":"Marenzana, M. & Arnett, T. R. The Key Role of the Blood Supply to Bone. Bone Res 1, 203\u201315 (2013).","journal-title":"Bone Res"},{"key":"BFsrep22868_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cytogfr.2013.03.008","volume":"24","author":"SM Chim","year":"2013","unstructured":"Chim, S. M. et al. Angiogenic factors in bone local environment. Cytokine Growth Factor Rev 24, 297\u2013310 (2013).","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFsrep22868_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.abb.2014.07.006","volume":"561","author":"U Saran","year":"2014","unstructured":"Saran, U., Gemini Piperni, S. & Chatterjee, S. Role of angiogenesis in bone repair. Arch Biochem Biophys 561, 109\u201317 (2014).","journal-title":"Arch Biochem Biophys"},{"key":"BFsrep22868_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/9467","volume":"5","author":"HP Gerber","year":"1999","unstructured":"Gerber, H. P. et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5, 623\u20138 (1999).","journal-title":"Nat Med"},{"key":"BFsrep22868_CR26","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/jbmr.1583","volume":"27","author":"H Oh","year":"2012","unstructured":"Oh, H. et al. Misexpression of Dickkopf-1 in endothelial cells, but not in chondrocytes or hypertrophic chondrocytes, causes defects in endochondral ossification. J Bone Miner Res 27, 1335\u201344 (2012).","journal-title":"J Bone Miner Res"},{"key":"BFsrep22868_CR27","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/S8756-3282(01)00608-1","volume":"29","author":"MR Hausman","year":"2001","unstructured":"Hausman, M. R., Schaffler, M. B. & Majeska, R. J. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 29, 560\u20134 (2001).","journal-title":"Bone"},{"key":"BFsrep22868_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00774-003-0487-6","volume":"22","author":"WJ Chen","year":"2004","unstructured":"Chen, W. J. et al. Effects of FGF-2 on metaphyseal fracture repair in rabbit tibiae. J Bone Miner Metab 22, 303\u20139 (2004).","journal-title":"J Bone Miner Metab"},{"key":"BFsrep22868_CR29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.bone.2004.02.027","volume":"35","author":"CA Simmons","year":"2004","unstructured":"Simmons, C. A., Alsberg, E., Hsiong, S., Kim, W. J. & Mooney, D. J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35, 562\u20139 (2004).","journal-title":"Bone"},{"key":"BFsrep22868_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jconrel.2010.07.097","volume":"147","author":"FR Formiga","year":"2010","unstructured":"Formiga, F. R. et al. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model. J Control Release 147, 30\u20137 (2010).","journal-title":"J Control Release"},{"key":"BFsrep22868_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00006534-200207000-00025","volume":"110","author":"PJ Bouletreau","year":"2002","unstructured":"Bouletreau, P. J. et al. Factors in the fracture microenvironment induce primary osteoblast angiogenic cytokine production. Plast Reconstr Surg 110, 139\u201348 (2002).","journal-title":"Plast Reconstr Surg"},{"key":"BFsrep22868_CR32","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/endo.143.4.8719","volume":"143","author":"MM Deckers","year":"2002","unstructured":"Deckers, M. M. et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143, 1545\u201353 (2002).","journal-title":"Endocrinology"},{"key":"BFsrep22868_CR33","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.430","volume":"28","author":"JS Lee","year":"2010","unstructured":"Lee, J. S. et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28, 1099\u2013106 (2010).","journal-title":"Stem Cells"},{"key":"BFsrep22868_CR34","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/bmt.2011.196","volume":"47","author":"DM Smadja","year":"2012","unstructured":"Smadja, D. M. et al. Angiogenic potential of BM MSCs derived from patients with critical leg ischemia. Bone Marrow Transplant 47, 997\u20131000 (2012).","journal-title":"Bone Marrow Transplant"},{"key":"BFsrep22868_CR35","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s12013-014-0369-7","volume":"71","author":"G Song","year":"2015","unstructured":"Song, G. et al. Transplantation of iPSc Restores Cardiac Function by Promoting Angiogenesis and Ameliorating Cardiac Remodeling in a Post-infarcted Swine Model. Cell Biochem Biophys 71, 1463\u20131473 (2015).","journal-title":"Cell Biochem Biophys"},{"key":"BFsrep22868_CR36","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1172\/JCI81423","volume":"125","author":"NA Manieri","year":"2015","unstructured":"Manieri, N. A. et al. Mucosally transplanted mesenchymal stem cells stimulate intestinal healing by promoting angiogenesis. J Clin Invest 125, 3606\u201318 (2015).","journal-title":"J Clin Invest"},{"key":"BFsrep22868_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.5966\/sctm.2012-0084","volume":"2","author":"DA Knorr","year":"2013","unstructured":"Knorr, D. A. et al. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy. Stem Cells Transl Med 2, 274\u201383 (2013).","journal-title":"Stem Cells Transl Med"},{"key":"BFsrep22868_CR38","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/stem.1611","volume":"32","author":"Z Ni","year":"2014","unstructured":"Ni, Z., Knorr, D. A., Bendzick, L., Allred, J. & Kaufman, D. S. Expression of chimeric receptor CD4zeta by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo . Stem Cells 32, 1021\u201331 (2014).","journal-title":"Stem Cells"},{"key":"BFsrep22868_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0020-1383(95)00135-2","volume":"26","author":"K Hietaniemi","year":"1995","unstructured":"Hietaniemi, K., Peltonen, J. & Paavolainen, P. An experimental model for non-union in rats. Injury 26, 681\u20136 (1995).","journal-title":"Injury"},{"key":"BFsrep22868_CR40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0736-0266(02)00209-7","volume":"21","author":"T Kokubu","year":"2003","unstructured":"Kokubu, T., Hak, D. J., Hazelwood, S. J. & Reddi, A. H. Development of an atrophic nonunion model and comparison to a closed healing fracture in rat femur. J Orthop Res 21, 503\u201310 (2003).","journal-title":"J Orthop Res"},{"key":"BFsrep22868_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/00005131-199902000-00008","volume":"13","author":"SH Park","year":"1999","unstructured":"Park, S. H., O'Connor, K., Sung, R., McKellop, H. & Sarmiento, A. Comparison of healing process in open osteotomy model and closed fracture model. J Orthop Trauma 13, 114\u201320 (1999).","journal-title":"J Orthop Trauma"},{"key":"BFsrep22868_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1479-5876-11-143","volume":"11","author":"PK Gupta","year":"2013","unstructured":"Gupta, P. K. et al. A double blind randomized placebo controlled phase I\/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia. J Transl Med 11, 143 (2013).","journal-title":"J Transl Med"},{"key":"BFsrep22868_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11936-014-0323-4","volume":"16","author":"R Thakker","year":"2014","unstructured":"Thakker, R. & Yang, P. Mesenchymal stem cell therapy for cardiac repair. Curr Treat Options Cardiovasc Med 16, 323 (2014).","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"BFsrep22868_CR44","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.actbio.2015.02.011","volume":"18","author":"P Wang","year":"2015","unstructured":"Wang, P. et al. Bone tissue engineering via human induced pluripotent, umbilical cord and bone marrow mesenchymal stem cells in rat cranium. Acta Biomater 18, 236\u201348 (2015).","journal-title":"Acta Biomater"},{"key":"BFsrep22868_CR45","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1038\/emm.2013.118","volume":"45","author":"IK Ko","year":"2013","unstructured":"Ko, I. K., Lee, S. J., Atala, A. & Yoo, J. J. In situ tissue regeneration through host stem cell recruitment. Exp Mol Med 45, e57 (2013).","journal-title":"Exp Mol Med"},{"key":"BFsrep22868_CR46","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nbt.2978","volume":"32","author":"SW Lane","year":"2014","unstructured":"Lane, S. W., Williams, D. A. & Watt, F. M. Modulating the stem cell niche for tissue regeneration. Nat Biotechnol 32, 795\u2013803 (2014).","journal-title":"Nat Biotechnol"},{"key":"BFsrep22868_CR47","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.bbrc.2012.08.095","volume":"426","author":"F Li","year":"2012","unstructured":"Li, F., Whyte, N. & Niyibizi, C. Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for paracrine activities in bone regeneration. Biochem Biophys Res Commun 426, 475\u20139 (2012).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep22868_CR48","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.biomaterials.2009.09.038","volume":"31","author":"F Tortelli","year":"2010","unstructured":"Tortelli, F., Tasso, R., Loiacono, F. & Cancedda, R. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials 31, 242\u20139 (2010).","journal-title":"Biomaterials"},{"key":"BFsrep22868_CR49","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.bone.2011.07.007","volume":"49","author":"T Histing","year":"2011","unstructured":"Histing, T. et al. Small animal bone healing models: standards, tips, and pitfalls results of a consensus meeting. Bone 49, 591\u20139 (2011).","journal-title":"Bone"},{"key":"BFsrep22868_CR50","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1089\/ten.tea.2008.0269","volume":"15","author":"R Tasso","year":"2009","unstructured":"Tasso, R. et al. Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic. Tissue Eng Part A 15, 2203\u201312 (2009).","journal-title":"Tissue Eng Part A"},{"key":"BFsrep22868_CR51","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s002640050060","volume":"20","author":"J Oda","year":"1996","unstructured":"Oda, J., Hirano, T., Iwasaki, K. & Majima, R. Vascular occlusion and cartilage disorders in osteonecrosis of the femoral head in rats. Int Orthop 20, 185\u20139 (1996).","journal-title":"Int Orthop"},{"key":"BFsrep22868_CR52","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ocl.2004.03.002","volume":"35","author":"EO Johnson","year":"2004","unstructured":"Johnson, E. O., Soultanis, K. & Soucacos, P. N. Vascular anatomy and microcirculation of skeletal zones vulnerable to osteonecrosis: vascularization of the femoral head. Orthop Clin North Am 35, 285\u201391, viii (2004).","journal-title":"Orthop Clin North Am"},{"key":"BFsrep22868_CR53","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1359\/JBMR.041226","volume":"20","author":"YC Huang","year":"2005","unstructured":"Huang, Y. C., Kaigler, D., Rice, K. G., Krebsbach, P. H. & Mooney, D. J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20, 848\u201357 (2005).","journal-title":"J Bone Miner Res"},{"key":"BFsrep22868_CR54","doi-asserted-by":"publisher","first-page":"9656","DOI":"10.1073\/pnas.152324099","volume":"99","author":"J Street","year":"2002","unstructured":"Street, J. et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99, 9656\u201361 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep22868_CR55","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1359-6101(96)00039-1","volume":"7","author":"M Goldfarb","year":"1996","unstructured":"Goldfarb, M. Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 7, 311\u201325 (1996).","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFsrep22868_CR56","doi-asserted-by":"publisher","first-page":"729352","DOI":"10.1155\/2015\/729352","volume":"2015","author":"Y Takei","year":"2015","unstructured":"Takei, Y., Minamizaki, T. & Yoshiko, Y. Functional diversity of fibroblast growth factors in bone formation. Int J Endocrinol 2015, 729352 (2015).","journal-title":"Int J Endocrinol"},{"key":"BFsrep22868_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.stem.2009.06.008","volume":"5","author":"MH Chin","year":"2009","unstructured":"Chin, M. H. et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5, 111\u201323 (2009).","journal-title":"Cell Stem Cell"},{"key":"BFsrep22868_CR58","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/ng.471","volume":"41","author":"A Doi","year":"2009","unstructured":"Doi, A. et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41, 1350\u20133 (2009).","journal-title":"Nat Genet"},{"key":"BFsrep22868_CR59","doi-asserted-by":"publisher","first-page":"e46770","DOI":"10.1371\/journal.pone.0046770","volume":"7","author":"JK Meissen","year":"2012","unstructured":"Meissen, J. K. et al. Induced pluripotent stem cells show metabolomic differences to embryonic stem cells in polyunsaturated phosphatidylcholines and primary metabolism. PLoS One 7, e46770 (2012).","journal-title":"PLoS One"},{"key":"BFsrep22868_CR60","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1073\/pnas.0910012107","volume":"107","author":"BY Hu","year":"2010","unstructured":"Hu, B. Y. et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 107, 4335\u201340 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep22868_CR61","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/stem.20080922","volume":"27","author":"KD Choi","year":"2009","unstructured":"Choi, K. D. et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27, 559\u201367 (2009).","journal-title":"Stem Cells"},{"key":"BFsrep22868_CR62","doi-asserted-by":"publisher","first-page":"e65324","DOI":"10.1371\/journal.pone.0065324","volume":"8","author":"CA Willmann","year":"2013","unstructured":"Willmann, C. A. et al. To clone or not to clone? Induced pluripotent stem cells can be generated in bulk culture. PLoS One 8, e65324 (2013).","journal-title":"PLoS One"},{"key":"BFsrep22868_CR63","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/stem.1016","volume":"30","author":"M Lohle","year":"2011","unstructured":"Lohle, M. et al. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Stem Cells 30, 570\u20139 (2011).","journal-title":"Stem Cells"},{"key":"BFsrep22868_CR64","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13045-014-0050-z","volume":"7","author":"J Li","year":"2014","unstructured":"Li, J., Song, W., Pan, G. & Zhou, J. Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells. J Hematol Oncol 7, 50 (2014).","journal-title":"J Hematol Oncol"},{"key":"BFsrep22868_CR65","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nbt.2052","volume":"29","author":"K Kim","year":"2011","unstructured":"Kim, K. et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol 29, 1117\u20139 (2011).","journal-title":"Nat Biotechnol"},{"key":"BFsrep22868_CR66","doi-asserted-by":"publisher","first-page":"e53771","DOI":"10.1371\/journal.pone.0053771","volume":"8","author":"A Nasu","year":"2013","unstructured":"Nasu, A. et al. Genetically matched human iPS cells reveal that propensity for cartilage and bone differentiation differs with clones, not cell type of origin. PLoS One 8, e53771 (2013).","journal-title":"PLoS One"},{"key":"BFsrep22868_CR67","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/TA.0b013e3181a7c16d","volume":"68","author":"DB Whelan","year":"2010","unstructured":"Whelan, D. B. et al. Development of the radiographic union score for tibial fractures for the assessment of tibial fracture healing after intramedullary fixation. J Trauma 68, 629\u201332 (2010).","journal-title":"J Trauma"},{"key":"BFsrep22868_CR68","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/jor.21106","volume":"28","author":"SG Hastrup","year":"2010","unstructured":"Hastrup, S. G. et al. Effect of nicotine and tobacco administration method on the mechanical properties of healing bone following closed fracture. J Orthop Res 28, 1235\u20139 (2010).","journal-title":"J Orthop Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep22868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep22868","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep22868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T04:10:15Z","timestamp":1672891815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep22868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,16]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,3,29]]}},"alternative-id":["BFsrep22868"],"URL":"https:\/\/doi.org\/10.1038\/srep22868","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,16]]},"assertion":[{"value":"23 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Kaufman serves as a consultant and has research support from Fate Therapeutics. This is unrelated to work in this manuscript. Other authors have declared that no conflict of interest exists.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22868"}}